We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

(Reuters) - Gilead Sciences said on Saturday that it entered into a partnership with Denmark's LEO Pharma to develop programs ...

After completing some research into Gilead's products and mapping out some product-by-product forecasts to 2030, including pipeline assets, I'll share some detailed analysis in this post ...

Gilead had been the darling of investors a few years ago, thanks to the unprecedented success of its hepatitis C products, led by Sovaldi - a drug candidate acquired as part of Gilead's $11 ...

The changes will result in one company focused exclusively on cancer cell therapies and another on strategic transactions to build a pipeline of innovative medicines.